Key result
BSA-adjusted contrast dosing yields similar aortic enhancement to body weight-based dosing during CT angiography.
Why the study?
The effect of adjusting contrast material volumes for patient body surface area on aortic enhancement during CT angiography needed investigation.
Does adjusting contrast material volume to body surface area improve the consistency of aortic enhancement compared to body weight adjustment in patients undergoing MDCT aortography?
Observational (n=89)
Does adjusting contrast material volume to body surface area improve the consistency of aortic enhancement compared to body weight adjustment in patients undergoing MDCT aortography?
Adjusting contrast material dose to body surface area rather than body weight provides consistent and adequate aortic enhancement during 64-MDCT aortography regardless of patient body weight.
Answers are grounded in this paper and cite their sources.
BSA-adjusted dosing may yield weight-independent aortic enhancement in MDCT aortography; leaves open prospective trials before practice change.
OBJECTIVE: The objective of our study was to investigate the effect on aortic enhancement of contrast material volumes adjusted for a patient's body surface area (BSA) at CT angiography (CTA). SUBJECTS AND METHODS: A 64-MDCT scanner was used to perform CTA of the whole aorta in 89 patients (mean age, 68.7 years) with confirmed or suspected aortoiliac disease. The patients were divided into groups: a body weight (BW) group (n = 45) and a BSA (n = 44) group. The contrast dose was 360 mg I/kg BW in the BW group and 12,753 mg I/m(2) BSA in the BSA group. Because the average BW of Japanese adults is approximately 60 kg, the contrast dose in the two protocols was identical in patients weighing 60 kg. We compared aortic enhancement achieved with the two protocols using the two-tailed Student's t test, and we used the generalized linear model to analyze the effect of patient age, sex, and BW on aortic enhancement in each protocol group. RESULTS: The mean aortic enhancement in the BW and BSA groups was 324.2 and 311.7 HU, respectively; the difference was not significant (p = 0.26). In the BW group, BW had a statistically significant effect on aortic enhancement (p < 0.01), whereas neither patient age nor sex did (p = 0.08 and 0.07, respectively). In the BSA group, the age, sex, BW, and BW by sex had no statistically significant effect on aortic enhancement (p = 0.33, 023, 0.10, and 0.16, respectively). CONCLUSION: Under the BSA protocol, aortic enhancement tended to be consistent and adequate regardless of patient BW.
No takes yet. Share an insight, caveat, or question.
Yanaga et al. (2010) conducted an observational in Confirmed or suspected aortoiliac disease (n=89). Contrast material dose adjusted for body surface area (BSA) vs. Contrast material dose adjusted for body weight (360 mg I/kg BW) was evaluated on Mean aortic enhancement (HU) (p=0.26). BSA-adjusted contrast dosing achieved similar mean aortic enhancement to BW-adjusted dosing while eliminating the confounding effect of body weight on enhancement.
Synapse has enriched 10 related papers. Consider them for comparative context: